aTyr Pharma Inc (LIFE)
2.00
+0.07
(+3.63%)
USD |
NASDAQ |
May 17, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Cash and Short Term Investments (Quarterly): 84.50M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 84.50M |
| December 31, 2023 | 98.17M |
| September 30, 2023 | 102.13M |
| June 30, 2023 | 108.58M |
| March 31, 2023 | 114.38M |
| December 31, 2022 | 66.15M |
| September 30, 2022 | 77.37M |
| June 30, 2022 | 88.55M |
| March 31, 2022 | 98.67M |
| December 31, 2021 | 107.91M |
| September 30, 2021 | 116.35M |
| June 30, 2021 | 44.06M |
| March 31, 2021 | 50.64M |
| December 31, 2020 | 31.69M |
| September 30, 2020 | 36.15M |
| June 30, 2020 | 41.43M |
| March 31, 2020 | 49.83M |
| December 31, 2019 | 31.14M |
| September 30, 2019 | 38.06M |
| Date | Value |
|---|---|
| June 30, 2019 | 42.40M |
| March 31, 2019 | 43.02M |
| December 31, 2018 | 49.54M |
| September 30, 2018 | 55.96M |
| June 30, 2018 | 64.33M |
| March 31, 2018 | 74.10M |
| December 31, 2017 | 85.12M |
| September 30, 2017 | 90.38M |
| June 30, 2017 | 57.22M |
| March 31, 2017 | 61.93M |
| December 31, 2016 | 72.15M |
| September 30, 2016 | 70.53M |
| June 30, 2016 | 83.93M |
| March 31, 2016 | 86.05M |
| December 31, 2015 | 95.54M |
| September 30, 2015 | 108.80M |
| June 30, 2015 | 102.96M |
| March 31, 2015 | 54.51M |
| December 31, 2014 | 15.85M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
31.14M
Minimum
Dec 2019
116.35M
Maximum
Sep 2021
71.41M
Average
71.76M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vaxart Inc | 36.66M |
| Allogene Therapeutics Inc | 384.86M |
| AIM ImmunoTech Inc | 13.07M |
| Protalix BioTherapeutics Inc | 48.49M |
| Armata Pharmaceuticals Inc | 37.86M |